Latest National Comprehensive Cancer Network Stories
Commends LCA Board Member Deborah Morosini, MD, on Appointment to NCCN Foundation Board and Continued Lung Cancer Activism WASHINGTON, Sept.
LOS ANGELES and THE WOODLANDS, Texas, Sept.
THE WOODLANDS, Texas, Sept.
RALEIGH, N.C., Aug. 12 /PRNewswire/ -- Cancer remains one of the most complex diseases with newer treatments evolving rapidly.
SANTA ROSA, Calif. and THE WOODLANDS, Texas, Aug.
PHILADELPHIA, Aug. 4 /PRNewswire/ -- ITA Partners, Inc., an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, is extending its decision-support services with the introduction of eviti(TM).
WALTHAM, Mass., July 29 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that in 2014, sales of drugs from multinational corporations will represent 92 percent of Mexico's non-small-cell lung cancer drug market.
CHICAGO, July 13 /PRNewswire/ -- After a successful pilot program in October 2009, Cancer Treatment Centers of America (CTCA) is introducing an innovative approach to cancer treatment this July at each of its four hospitals in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix.
THE WOODLANDS, Texas, June 10 /PRNewswire/ -- Three clinical trials studies with prominent authorship by physicians affiliated with the United Network of US Oncology have been selected to be featured in the Best of ASCO to be held July 16 - 17 in San Francisco and July 23 -24 in Boston.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.